Last Updated on April 20, 2024 by The Health Master
73rd IPC
The City of Pearls, Hyderabad, is poised to become a hub of knowledge exchange and innovation in the pharmaceutical sector as it gears up to host the prestigious 73rd IPC (Indian Pharmaceutical Congress) from July 5th to 7th, 2024.
This much-anticipated event, returning to Hyderabad after nine years, carries the powerful theme: “Role of Indian Pharma for Global Wellbeing”.
Hyderabad: A Pharmaceutical Powerhouse
Hyderabad’s selection as the host city is no coincidence. It’s a strategic decision reflecting the city’s well-deserved reputation as India’s pharmaceutical powerhouse.
- Thriving Ecosystem: Hyderabad boasts a robust ecosystem of research institutions, manufacturing facilities, and esteemed pharmacy colleges. This comprehensive infrastructure fosters collaboration and facilitates advancements in drug discovery and development.
- Global Leader in Generics: India is a world leader in generic drug manufacturing, and Hyderabad is at the forefront of this success story. The city plays a vital role in ensuring the affordability and accessibility of essential medications across the globe.
Related News: The IPC 2024: Fostering Industry Growth in Hyderabad
A Platform for Collaboration and Progress
The IPC Congress serves as a vital platform for key stakeholders in the pharmaceutical industry:
- Industry Leaders & Researchers: The event fosters collaboration between industry leaders and researchers, allowing them to exchange ideas and showcase groundbreaking innovations in drug development, manufacturing, and research.
- Policymakers & Stakeholders: Policymakers and stakeholders come together to discuss emerging trends, challenges, and opportunities in the pharmaceutical sector. The focus lies on enhancing healthcare access, affordability, and quality for a healthier global population.
Telangana’s Commitment to Global Health
The return of the IPC to Hyderabad underscores Telangana’s unwavering commitment to advancing global health. The state actively promotes collaborative efforts between the government and the pharmaceutical industry.
This synergy aims to:
- Hub for Pharmaceutical Excellence: Position India as a global hub for pharmaceutical research, manufacturing, and exports.
- Enhanced Global Wellbeing: Contribute significantly to improving global health outcomes through research and development.
Leading Figures Shaping the Event
A distinguished panel of industry leaders will guide the 73rd IPC:
- Dr. Bandi Parthasaradhi Reddy: President-elect, Hetero Drugs
- Dr. TV Narayana: National President, Indian Pharmaceutical Association & Hon. Secretary, Indian Pharmaceutical Congress Association
- JAS Giri: Chairman of the Local Organizing Committee
- Dr. Ramakrishna: Secretary of the Local Organizing Committee and DDC India, CDSCO
- T Jayapal Reddy: Joint Secretary, Local Organizing Committee
Spotlight on Innovation and Advancement
Dr. Narayana, National President of the Indian Pharmaceutical Association (IPA), highlights that the event will focus on the latest advancements in the pharmaceutical field, encompassing:
- Scientific Breakthroughs: The congress will showcase cutting-edge research and development (R&D) efforts in drug discovery.
- Academic & Professional Challenges: Discussions will address the challenges faced by academics, hospital pharmacists, and community pharmacists.
Hyderabad: A City of Pharmaceutical Excellence
Hyderabad’s pivotal role in the pharmaceutical industry is undeniable:
- Bulk Drug Capital: The city is the undisputed bulk drug capital of India, contributing over 40% of the nation’s production.
- Vaccine Production Hub: Hyderabad is also India’s vaccine capital, playing a crucial role in developing and manufacturing life-saving vaccines, including:
- Dr. Reddy’s Labs’ innovative wearable therapy device for migraine management
- Bharat Biotech’s Covaxin for COVID-19 prevention
- Biological E’s Corbevax, India’s first indigenous protein sub-unit COVID-19 vaccine
- A Breeding Ground for Innovation: Leading pharmaceutical companies like Aurobindo Pharma, Divi’s Laboratories, Laurus Labs, and Lonza all call Hyderabad home, solidifying the city’s position as a future-oriented pharmaceutical hub.
- Infrastructure & Development: The upcoming pharma parks in Mucherla and the proposed Hyderabad Pharma City project showcase the city’s commitment to further develop its pharmaceutical infrastructure.
Hyderabad’s Ranking & Economic Strength
Dr. Narayana emphasizes Hyderabad’s position as a leader in innovation and economic growth:
- Innovation Hub: Ranked second in the 2022 Innovation Index, Hyderabad is a recognized hub for cutting-edge advancements.
- Economic Powerhouse: The city boasts the highest per capita income in India for the financial year 2022-23.
The 73rd IPC promises to be a landmark event, further solidifying Hyderabad’s position as a global leader in the pharmaceutical industry.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA Inspection: At Strides Pharma with 2 observations
Drug recall: Drugs recalled by these Indian Pharma Companies
PCI to conduct GPAT exams on June 8
USFDA approval granted for First Generic Injection for Breast Cancer
CDSCO Seeks More Medical Device Testing Laboratory Registrations
USFDA issues Warning Letter to Natco Pharma for Telangana Plant
USFDA completes inspection at Aurobindo with 3 observations
CDSCO Approval granted for Early Cancer Detection Test
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
